• Company
    • Leadership
      • Management Team
      • Board of Directors
    • Partners
      • Research Partners
      • Investors
    • Careers
      • Open Positions
  • Approach
    • Redefining Disease
      • Precision Medicine
      • Genetically-Defined AMD
    • Understanding Ocular Disease
      • CLARITY Studies
    • Therapeutic Modalities
      • Therapeutic Approach
      • Recombinant Proteins
      • Gene Therapy
      • Monoclonal Antibodies
  • Pipeline
    • Programs
      • Complement Factor H
    • Scientific Advisors
      • Founders
      • Advisory Board
  • News
    • Presentations
  • Contact
Gemini Therapeutics Logo
  • Company
    • Leadership
      • Management Team
      • Board of Directors
    • Partners
      • Research Partners
      • Investors
    • Careers
      • Open Positions
  • Approach
    • Redefining Disease
      • Precision Medicine
      • Genetically-Defined AMD
    • Understanding Ocular Disease
      • CLARITY Studies
    • Therapeutic Modalities
      • Therapeutic Approach
      • Recombinant Proteins
      • Gene Therapy
      • Monoclonal Antibodies
  • Pipeline
    • Programs
      • Complement Factor H
    • Scientific Advisors
      • Founders
      • Advisory Board
  • News
    • Presentations
  • Contact
Home Pipeline Scientific Founders

Scientific Founders

Gemini was founded in 2015 with the vision and guidance of scientific co-founders Johanna Seddon, Paul Barlow and Andrew Herbert.

Share:

  • LinkedIn
  • Twitter
  • Facebook
  • Portrait of Paul Barlow

    Paul Barlow, Ph.D.

    The University of Edinburgh
  • Portrait of Andrew Herbert

    Andrew Herbert, Ph.D.

    The University of Edinburgh
  • Portrait of Johanna M. Seddon

    Johanna M. Seddon, M.D., Sc.M.

    University of Massachusetts Medical School
Complement Factor H
Scientific Advisory Board
Gemini Therapeutics Logo
  • Contact
  • Privacy Policy
  • Follow:
© 2020 Gemini Therapeutics